Cochrane Abstracts
Bromocriptine versus levodopa in early Parkinson's disease
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Bromocriptine Versus Levodopa in Early Parkinson's Disease." Cochrane Abstracts, John Wiley & Sons, Inc, 2024. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/435315/all/Bromocriptine_versus_levodopa_in_early_Parkinson's_disease.
Bromocriptine versus levodopa in early Parkinson's disease. Cochrane Abstracts. John Wiley & Sons, Inc; 2024. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435315/all/Bromocriptine_versus_levodopa_in_early_Parkinson's_disease. Accessed November 24, 2024.
Bromocriptine versus levodopa in early Parkinson's disease. (2024). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/435315/all/Bromocriptine_versus_levodopa_in_early_Parkinson's_disease
Bromocriptine Versus Levodopa in Early Parkinson's Disease [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2024. [cited 2024 November 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/435315/all/Bromocriptine_versus_levodopa_in_early_Parkinson's_disease.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Bromocriptine versus levodopa in early Parkinson's disease
ID - 435315
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/435315/all/Bromocriptine_versus_levodopa_in_early_Parkinson's_disease
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
